Not yet recruiting
Efficacy and Safety of Tazbentetol in ALS Participants
NCT07325591
- Conditions
- Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
- Locations
-
Not specified